10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.92%
Negative EBIT growth while OR is at 15.15%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.52%
Negative operating income growth while OR is at 7.56%. Joel Greenblatt would press for urgent turnaround measures.
-10.21%
Negative net income growth while OR stands at 26.20%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.62%
Negative EPS growth while OR is at 21.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.62%
Negative diluted EPS growth while OR is at 21.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
13.35%
Share count expansion well above OR's 0.41%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.35%
Diluted share count expanding well above OR's 0.35%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
16.78%
OCF growth 1.25-1.5x OR's 11.49%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
-144.35%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-482.18%
Negative 10Y net income/share CAGR while OR is at 301.80%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-482.18%
Negative 5Y net income/share CAGR while OR is 117.59%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-482.18%
Negative 3Y CAGR while OR is 86.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-40.18%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-40.18%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-40.18%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
85.79%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-17.27%
Negative asset growth while OR invests at 3.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-28.20%
We have a declining book value while OR shows 5.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.56%
SG&A declining or stable vs. OR's 19.74%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.